BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 21731759)

  • 1. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
    Guo S; Gonzalez-Perez RR
    PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling.
    Zhou W; Guo S; Gonzalez-Perez RR
    Br J Cancer; 2011 Jan; 104(1):128-37. PubMed ID: 21139583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance.
    Daley-Brown D; Harbuzariu A; Kurian AA; Oprea-Ilies G; Gonzalez-Perez RR
    World J Clin Oncol; 2019 Jun; 10(6):222-233. PubMed ID: 31367531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation.
    Lanier V; Gillespie C; Leffers M; Daley-Brown D; Milner J; Lipsey C; Webb N; Anderson LM; Newman G; Waltenberger J; Gonzalez-Perez RR
    Int J Biochem Cell Biol; 2016 Oct; 79():139-150. PubMed ID: 27590851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NILCO biomarkers in breast cancer from Chinese patients.
    Colbert LS; Wilson K; Kim S; Liu Y; Oprea-Ilies G; Gillespie C; Dickson T; Newman G; Gonzalez-Perez RR
    BMC Cancer; 2014 Apr; 14():249. PubMed ID: 24716804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity induced a leptin-Notch signaling axis in breast cancer.
    Battle M; Gillespie C; Quarshie A; Lanier V; Harmon T; Wilson K; Torroella-Kouri M; Gonzalez-Perez RR
    Int J Cancer; 2014 Apr; 134(7):1605-16. PubMed ID: 24114531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells.
    Knight BB; Oprea-Ilies GM; Nagalingam A; Yang L; Cohen C; Saxena NK; Sharma D
    Endocr Relat Cancer; 2011 Aug; 18(4):413-28. PubMed ID: 21555376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
    Shi J; Lu Y; Wei P
    J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
    You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
    J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin-cytokine crosstalk in breast cancer.
    Newman G; Gonzalez-Perez RR
    Mol Cell Endocrinol; 2014 Jan; 382(1):570-582. PubMed ID: 23562747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis.
    Ohnuki H; Inoue H; Takemori N; Nakayama H; Sakaue T; Fukuda S; Miwa D; Nishiwaki E; Hatano M; Tokuhisa T; Endo Y; Nose M; Higashiyama S
    Blood; 2012 Mar; 119(11):2688-98. PubMed ID: 22279058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin's Pro-Angiogenic Signature in Breast Cancer.
    Gonzalez-Perez RR; Lanier V; Newman G
    Cancers (Basel); 2013 Sep; 5(3):1140-62. PubMed ID: 24202338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
    Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
    Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2).
    Gonzalez RR; Cherfils S; Escobar M; Yoo JH; Carino C; Styer AK; Sullivan BT; Sakamoto H; Olawaiye A; Serikawa T; Lynch MP; Rueda BR
    J Biol Chem; 2006 Sep; 281(36):26320-8. PubMed ID: 16825198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Notch, IL-1 and leptin expression in colorectal cancer.
    Erkasap N; Ozyurt R; Ozkurt M; Erkasap S; Yasar F; Ihtiyar E; Ciftci E; Canaz F; Colak E
    Exp Ther Med; 2021 Jun; 21(6):600. PubMed ID: 33884038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells.
    Carino C; Olawaiye AB; Cherfils S; Serikawa T; Lynch MP; Rueda BR; Gonzalez RR
    Int J Cancer; 2008 Dec; 123(12):2782-90. PubMed ID: 18798554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-secretase Inhibitor Prevents Proliferation and Migration of Ductus Arteriosus Smooth Muscle Cells through the Notch3-HES1/2/5 Pathway.
    Wu JR; Yeh JL; Liou SF; Dai ZK; Wu BN; Hsu JH
    Int J Biol Sci; 2016; 12(9):1063-73. PubMed ID: 27570480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation.
    Daley-Brown D; Oprea-Iles G; Vann KT; Lanier V; Lee R; Candelaria PV; Quarshie A; Pattillo R; Gonzalez-Perez RR
    Dis Markers; 2017; 2017():8248175. PubMed ID: 28659656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
    Saltarella I; Frassanito MA; Lamanuzzi A; Brevi A; Leone P; Desantis V; Di Marzo L; Bellone M; Derudas D; Ribatti D; Chiaramonte R; Palano MT; Neri A; Mariggiò MA; Fumarulo R; Dammacco F; Racanelli V; Vacca A; Ria R
    Neoplasia; 2019 Jan; 21(1):93-105. PubMed ID: 30529074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.